Name of bioresource/bank
Scottish National Tissue Collection [under development]
Name of Principal Investigator
| Title | Dr |
| First name | Alan |
| Last name | McNair |
Address of institution where award is held
| Institution | Chief Scientist Office |
| Street Address | St Andrew’s House, Regent Rd |
| City | Edinburgh |
| Postcode | EH1 3DG |
Country
United Kingdom
Website
http://www.show.scot.nhs.uk/cso
Contact email (e.g. manager or coordinator)
Funding source
Chief Scientist Office
Q1 What conditions does your resource cover?
Neurodegenerative disease in general
Q2a What DNA collection does your resources hold?
None
Q2b What cell lines does your resource hold?
None
Q2c What tissue (including post-mortem tissue) does your resource hold?
Above 5000 donors
Q3 Are human tissues/samples/DNA from
Living donors:blood Living donors: blood derivatives Living donors: peripheral nerve biopsy Living donors: skeletal muscle biopsy Living donors: cerebro-spinal fluid Living donors: other non-neural tissue such as lymph nodes
Q4 Are tissues/samples/DNA from
Patients
Q5 Can samples be linked to clinical (phenotypic) information and if so, is this information:
Routinely collected as medical records
Q6 In what form are samples supplied?
Primary samples: Supplied fresh Primary Samples: Stabilised samples (frozen or fixed) Primary Samples: Stabilised samples (frozen or fixed) Secondary samples:(derivatives of primary samples)
Q7 Are biomarkers/analytes/biological characteristics already measured and the information available for your samples?
In a few samples
Q8 What is the status of your tissue/sample/DNA collection?
Q9 What are the rules and procedures for access?
Local/ regional access National access International access Access to industry Resource has own ethics approval so usually no need for separate external ethics approval